L472-1322 Screening compound: 3-[4-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole

L472-1322 Screening compound: 3-[4-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole
L472-1322 Screening compound: 3-[4-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound L472-1322
3-[4-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L472-1322

Molecular Formula

C23H21N3O4S (C23 H21 N3 O4 S)

Compound Name

3-[4-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,2,4-oxadiazole

IUPAC name

3-[4-(2-cyclopropyl-13-thiazol-4-yl)phenyl]-5-(345-trimethoxyphenyl)-124-oxadiazole

SMILES

COc1cc(-c2nc(-c(cc3)ccc3-c3csc(C4CC4)n3)no2)cc(OC)c1OC

InChI

InChI=1S/C23H21N3O4S/c1-27-18-10-16(11-19(28-2)20(18)29-3)22-25-21(26-30-22)14-6-4-13(5-7-14)17-12-31-23(24-17)15-8-9-15/h4-7,10-12,15H,8-9H2,1-3H3

InChI Key

JGFODBKDUSHYDG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27455092

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.580

Distribution Coefficient, logD

5.580

Water Solubility, LogSw

-5.56

Polar Surface Area

64.608

Acid Dissociation Constant (pKa)

23.73

Base Dissociation Constant (pKb)

2.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.10

L472-1322 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L472-1322 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L472-1322?
Check Price and Availability of L472-1322, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L472-1322 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L472-1322
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L472-1322
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L472-1322 available by request